Table 3 Comparison of the demographic characteristics and conventional imaging findings between viable and non-viable territories.
Demographics | LAD | RCA | LCX | ||||||
|---|---|---|---|---|---|---|---|---|---|
Non-viable N=32 | Viable N=47 | P value | Non-viable N=26 | Viable N=53 | P value | Non-viable N=25 | Viable N=54 | P value | |
Hypertension | 17(56.66) | 17(43.58) | 0.18 | 13(56.52) | 21(45.65) | 0.75 | 11(52.38) | 23(47.91) | 0.53 |
Diabetes | 13(43.33) | 13(33.33) | 0.56 | 10(43.47) | 16(34.78) | 0.92 | 10(47.61) | 16(33.33) | 0.36 |
Hyperlipidemia | 11(36.66) | 10(25.64) | 0.78 | 8(34.78) | 13(28.26) | 0.35 | 4(19.04) | 17(35.41) | 0.36 |
Smoke | 15(50) | 13(33.33) | 0.64 | 10(43.47) | 18(39.13) | 0.92 | 9(42.85) | 19(39.58) | 0.58 |
Age | 45.96±12.64 | 49.41±12.44 | 0.24 | 43.92±11.19 | 50.04±12.82 | 0.05 | 45.52±12.54 | 49.07±12.53 | 0.26 |
Imaging findings | |||||||||
LA area | 23.32±9.87 | 23.74±13.64 | 0.88 | 24.56±10.55 | 23.03±12.85 | 0.61 | 27.06±12.96 | 22.04±11.45 | 0.10 |
RA area | 19.04±12.62 | 20.71±21.98 | 0.70 | 21.26±14.68 | 19.30±20.29 | 0.66 | 20.13±6.75 | 19.93±21.62 | 0.96 |
LVEF | 26.18±8.00 | 29.61±11.67 | 0.15 | 26.15±7.24 | 29.20±11.59 | 0.22 | 24.95±7.31 | 29.48±11.16 | 0.08 |
EDVI | 136.46±78.76 | 128.30±48.10 | 0.58 | 122.96±46.42 | 136.64±70.16 | 0.37 | 147.5±65.40 | 125.21±61.18 | 0.16 |
ESVI | 106.87±68.23 | 92.92±42.01 | 0.28 | 95.57±35.81 | 100.79±63.20 | 0.69 | 112.22±58.41 | 93.34±52.96 | 0.17 |
LVSV | 56.78±17.14 | 60.58±18.47 | 0.37 | 57.32±19.28 | 59.75±17.26 | 0.58 | 59±16.95 | 58.88±18.43 | 0.98 |
RVEF | 45.65±12.67 | 43.85±11.60 | 0.52 | 42.42±12.23 | 45.83±11.86 | 0.24 | 42.27±15.38 | 45.63±10.29 | 0.35 |
RVEDVI | 81.93±45.09 | 76.19±32.49 | 0.52 | 79.92±33.19 | 78.00±41.08 | 0.83 | 87.77±50.42 | 74.82±31.60 | 0.18 |
RVESVI | 47.84±38.47 | 43.76±24.85 | 0.58 | 48.53±29.83 | 43.89±32.26 | 0.54 | 56.36±47.67 | 40.94±19.86 | 0.15 |
RVSV | 53.14±13.96 | 55.91±19.02 | 0.52 | 51.18±13.87 | 56.634±18.29 | 0.22 | 55±14.10 | 54.60±18.30 | 0.93 |
